Trimethylamine N‐oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction
Abstract Aims Trimethylamine N‐oxide (TMAO) is a metabolite derived from the gut microbiota. Elevated TMAO levels are associated with a poor prognosis in patients with heart failure with reduced ejection fraction. However, the prognostic effect of elevated TMAO levels on heart failure with preserved...
Main Authors: | Yoshiharu Kinugasa, Kensuke Nakamura, Hiroko Kamitani, Masayuki Hirai, Kiyotaka Yanagihara, Masahiko Kato, Kazuhiro Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13290 |
Similar Items
-
Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness—A Practical Preventing Recommendation and Therapies
by: Edoardo Tacconi, et al.
Published: (2023-01-01) -
Adiposity and clinical outcomes in East Asian patients with heart failure and preserved ejection fraction
by: Yuko Seki, et al.
Published: (2023-02-01) -
The Effect of Oral L-carnitine on Serum Albumin and Inflammatory Markers Levels in Patients under Peritoneal Dialysis: A Randomized Controlled Trial
by: Mojgan Mortazavi, et al.
Published: (2011-07-01) -
Change in Nutritional Status during Hospitalization and Prognosis in Patients with Heart Failure with Preserved Ejection Fraction
by: Akihiro Sunaga, et al.
Published: (2022-10-01) -
The Mitochondrial Carnitine Acyl-carnitine Carrier (SLC25A20): Molecular Mechanisms of Transport, Role in Redox Sensing and Interaction with Drugs
by: Annamaria Tonazzi, et al.
Published: (2021-03-01)